Literature DB >> 1488129

Distribution of thyrotropin-releasing hormone receptor messenger RNA in the rat brain: an in situ hybridization study.

L Calzá1, L Giardino, S Ceccatelli, M Zanni, R Elde, T Hökfelt.   

Abstract

Based on the recent cloning of the mouse thyrotropin-releasing hormone receptor, oligonucleotide probes complementary to the DNA sequence were constructed and used for in situ hybridization studies on the rat brain. Thyrotropin-releasing hormone receptor messenger RNA was found in many areas of the brain, mostly showing high degree of overlap with the distribution thyrotropin-releasing hormone binding sites as previously revealed in autoradiographic studies. Thus, a strong signal was observed in the accessory olfactory bulb, the perirhinal sulcus, the ventral aspects of the hippocampal formation, some amygdaloid nuclei, the diagonal band nucleus, parts of nucleus accumbens, the bed nucleus of the stria terminalis, dorsomedial, lateral and perifornical hypothalamic regions, the septohippocampal nucleus, parts of the vestibular complex, as well as many bulbar motoneurons including the facial, dorsal vagal, ambiguus and hypoglossal nuclei, the superficial layer of the spinal trigeminal nucleus, and motoneurons and dorsal horn neurons in the spinal cord. Cells within one and the same nucleus expressed varying levels of thyrotropin releasing hormone receptor messenger RNA suggesting marked differences in rate of receptor synthesis. Most of these areas receive an input by thyrotropin-releasing hormone-positive nerve endings. Taken together these results suggest that thyrotropin-releasing hormone receptors are mostly localized in the vicinity of the cell bodies which express thyrotropin-releasing hormone receptor messenger RNA and mediate the wide range of actions that have been recorded after administration of exogenous thyrotropin-releasing hormone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1488129     DOI: 10.1016/0306-4522(92)90528-a

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

1.  Morphofunctional changes due to thyroliberin in nonapeptidergic cells in living hippocampal slices from rats.

Authors:  M V Glazova; I A Krasnovskaya
Journal:  Neurosci Behav Physiol       Date:  2001 May-Jun

2.  Distribution and axonal projections of neurons coexpressing thyrotropin-releasing hormone and urocortin 3 in the rat brain.

Authors:  Gábor Wittmann; Tamás Füzesi; Zsolt Liposits; Ronald M Lechan; Csaba Fekete
Journal:  J Comp Neurol       Date:  2009-12-20       Impact factor: 3.215

Review 3.  Synaptic control of motoneuronal excitability.

Authors:  J C Rekling; G D Funk; D A Bayliss; X W Dong; J L Feldman
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

4.  Hyperthyroidism decreases thyrotropin-releasing hormone gene expression in the caudal raphe nuclei and the parapyramidal regions in rats.

Authors:  P Q Yuan; H Yang
Journal:  Neurosci Lett       Date:  1999-12-10       Impact factor: 3.046

5.  The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb.

Authors:  Vilborg Matre; Per I Høvring; Ase-Karine Fjeldheim; Lars Helgeland; Christophe Orvain; Kristin B Andersson; Kaare M Gautvik; Odd S Gabrielsen
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

6.  Neuropeptidomics of the Rat Habenular Nuclei.

Authors:  Ning Yang; Krishna D B Anapindi; Stanislav S Rubakhin; Pingli Wei; Qing Yu; Lingjun Li; Paul J Kenny; Jonathan V Sweedler
Journal:  J Proteome Res       Date:  2018-03-20       Impact factor: 4.466

7.  Feedback regulation of thyrotropin-releasing hormone gene expression by thyroid hormone in the caudal raphe nuclei in rats.

Authors:  H Yang; P Yuan; V Wu; Y Taché
Journal:  Endocrinology       Date:  1999-01       Impact factor: 4.736

8.  Potassium currents operated by thyrotrophin-releasing hormone in dissociated CA1 pyramidal neurones of rat hippocampus.

Authors:  S Ebihara; N Akaike
Journal:  J Physiol       Date:  1993-12       Impact factor: 5.182

Review 9.  Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles.

Authors:  Michael J Kubek; Abraham J Domb; Michael C Veronesi
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 10.  The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

Authors:  Jean-Louis Charli; Adair Rodríguez-Rodríguez; Karina Hernández-Ortega; Antonieta Cote-Vélez; Rosa María Uribe; Lorraine Jaimes-Hoy; Patricia Joseph-Bravo
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.